Abstract Details
|
Ann H. Tilton, MD, FÂ鶹´«Ã½Ó³»
(LSUHSC and Childrens Hospital of New Orleans)
PRESENTER |
Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date. |
| No disclosure on file | |
| No disclosure on file | |
| Gustavo A. Suarez-Zambrano, MD | Dr. Suarez-Zambrano has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America. |
| Philippe Picaut | No disclosure on file |
| Mauricio R. Delgado, MD, FRCPC, FÂ鶹´«Ã½Ó³» | Dr. Delgado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Delgado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Delgado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kashiv. The institution of Dr. Delgado has received research support from Ipsen. |